Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLASSIC: IV Fluid Restriction in Septic Shock
NCT03668236Phase 4Completed
- Start
- Nov 2018
- Primary completion
- Feb 2022
- Countries
- 8
01
Overview
Phase 4, randomised, open-label trial in septic shock (2 arms). Primary endpoint: 90-day Mortality. Started Nov 2018; status: completed.
02
Conditions
septic shock
Beyond the preview
Go deeper on NCT03668236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668236.